The expression levels of ACSL1, ACSL4, and ACSL5 are regulated by the estrogen receptor signaling pathway, and ACSL5 is a potential novel biomarker to predict the prognosis of breast cancer patients.309. This evidence concerns the gene ACSL4 and breast carcinoma.